Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-09 @ 6:20 PM
Study NCT ID:
NCT02554851
Status:
UNKNOWN
Last Update Posted:
2023-06-15
First Post:
2015-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
Sponsor:
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2015-09-11
First Submit QC Date:
None
Study First Post Date:
2015-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL